申请人:Zembower David E.
公开号:US20100137285A1
公开(公告)日:2010-06-03
The present invention provides compounds having formula (I) or (II):
and pharmaceutically acceptable derivatives thereof, wherein m, p, R
1
, R
2
, R
3
and R
4
are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of diseases, disorders or conditions associated with HGF/SF or other cytokine activity.